search
Back to results

Infracalcaneal Peppering Injection Technique for Chronic Plantar Fasciitis

Primary Purpose

Chronic Plantar Fasciitis

Status
Not yet recruiting
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Corticosteroid injection (CSI) with local anesthetic (LA)
Local anesthetic (LA) with Saline injection
Sponsored by
Wake Forest University Health Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Plantar Fasciitis focused on measuring corticosteroid injection, infracalcaneal peppering injection, Plantar Fasciitis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Men and women 18 years of age and older Patient reported history of plantar heel pain and confirmed clinical tenderness of pain with direct palpation of the medial calcaneal tubercle on baseline exam Diagnosis of chronic plantar fasciitis, defined for study purposes as symptoms greater than or equal to 6 weeks in duration Exclusion Criteria: Individuals less than 18 years of age Pregnancy History of local heel injection (i.e. corticosteroid injection (CSI) or other injectate) History of diabetes mellitus History of inflammatory arthritis Prior heel trauma or surgery Allergy to local corticosteroid or local anesthesia

Sites / Locations

  • Wake Forest University Health Sciences

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

corticosteroid injection/ local anesthetic (CSI/LA)

local anesthetic (LA)/Saline injection

Arm Description

The PI will then administer the (CSI/LA) injection using an infracalcaneal needle peppering technique as follows: The hypodermic needle is inserted using infracalcaneal injection approach. The hypodermic needle is withdrawn while at the same depositing injectate The hypodermic needle is redirected without emerging from the skin. The PI will perform steps 1-3 standardly 20-25 times.

The PI will then administer the (LA/Saline) injection using an infracalcaneal needle peppering technique as follows: The hypodermic needle is inserted using infracalcaneal injection approach. The hypodermic needle is withdrawn while at the same depositing injectate The hypodermic needle is redirected without emerging from the skin. The PI will perform steps 1-3 standardly 20-25 times.

Outcomes

Primary Outcome Measures

Change in Visual Analog Scale as a Comprehensible Patient-Reported Outcome Measure (VAS PROM) scores - heel tenderness
"general heel pain" - A sheet of paper with a printed VAS scale will be given to the patient. The patient will be instructed to make a bold dot on the line based on how they rate their general heel pain, using the parameters listed on the scale (0 meaning no pain, 20 meaning mild pain, 50 meaning moderate pain, 80 meaning extreme pain, and 100 meaning the worst pain imaginable). Range = 0-100 mm.
Change in Visual Analog Scale as a Comprehensible Patient-Reported Outcome Measure (VAS PROM) scores - heel tenderness
"general heel pain" - A sheet of paper with a printed VAS scale will be given to the patient. The patient will be instructed to make a bold dot on the line based on how they rate their general heel pain, using the parameters listed on the scale (0 meaning no pain, 20 meaning mild pain, 50 meaning moderate pain, 80 meaning extreme pain, and 100 meaning the worst pain imaginable). Range = 0-100 mm.
Change in Visual Analog Scale as a Comprehensible Patient-Reported Outcome Measure (VAS PROM) scores - heel tenderness
"general heel pain" - A sheet of paper with a printed VAS scale will be given to the patient. The patient will be instructed to make a bold dot on the line based on how they rate their general heel pain, using the parameters listed on the scale (0 meaning no pain, 20 meaning mild pain, 50 meaning moderate pain, 80 meaning extreme pain, and 100 meaning the worst pain imaginable). Range = 0-100 mm.
Change in Visual Analog Scale as a Comprehensible Patient-Reported Outcome Measure (VAS PROM) scores - heel tenderness
"general heel pain" - A sheet of paper with a printed VAS scale will be given to the patient. The patient will be instructed to make a bold dot on the line based on how they rate their general heel pain, using the parameters listed on the scale (0 meaning no pain, 20 meaning mild pain, 50 meaning moderate pain, 80 meaning extreme pain, and 100 meaning the worst pain imaginable). Range = 0-100 mm.
Change in Visual Analog Scale as a Comprehensible Patient-Reported Outcome Measure (VAS PROM) scores - heel tenderness
"general heel pain" - A sheet of paper with a printed VAS scale will be given to the patient. The patient will be instructed to make a bold dot on the line based on how they rate their general heel pain, using the parameters listed on the scale (0 meaning no pain, 20 meaning mild pain, 50 meaning moderate pain, 80 meaning extreme pain, and 100 meaning the worst pain imaginable). Range = 0-100 mm.
Change in Visual Analog Scale as a Comprehensible Patient-Reported Outcome Measure (VAS PROM) scores - first step pain
"first step pain" - A sheet of paper with a printed VAS scale will be given to the patient. The patient will be instructed to make a bold dot on the line based on how they rate their first step heel pain, using the parameters listed on the scale (0 meaning no pain, 20 meaning mild pain, 50 meaning moderate pain, 80 meaning extreme pain, and 100 meaning the worst pain imaginable). Range = 0-100 mm.
Change in Visual Analog Scale as a Comprehensible Patient-Reported Outcome Measure (VAS PROM) scores - first step pain
"first step pain" - A sheet of paper with a printed VAS scale will be given to the patient. The patient will be instructed to make a bold dot on the line based on how they rate their first step heel pain, using the parameters listed on the scale (0 meaning no pain, 20 meaning mild pain, 50 meaning moderate pain, 80 meaning extreme pain, and 100 meaning the worst pain imaginable). Range = 0-100 mm.
Change in Visual Analog Scale as a Comprehensible Patient-Reported Outcome Measure (VAS PROM) scores - first step pain
"first step pain" - A sheet of paper with a printed VAS scale will be given to the patient. The patient will be instructed to make a bold dot on the line based on how they rate their first step heel pain, using the parameters listed on the scale (0 meaning no pain, 20 meaning mild pain, 50 meaning moderate pain, 80 meaning extreme pain, and 100 meaning the worst pain imaginable). Range = 0-100 mm.
Change in Visual Analog Scale as a Comprehensible Patient-Reported Outcome Measure (VAS PROM) scores - first step pain
"first step pain" - A sheet of paper with a printed VAS scale will be given to the patient. The patient will be instructed to make a bold dot on the line based on how they rate their first step heel pain, using the parameters listed on the scale (0 meaning no pain, 20 meaning mild pain, 50 meaning moderate pain, 80 meaning extreme pain, and 100 meaning the worst pain imaginable). Range = 0-100 mm.
Change in Visual Analog Scale as a Comprehensible Patient-Reported Outcome Measure (VAS PROM) scores - first step pain
"first step pain" - A sheet of paper with a printed VAS scale will be given to the patient. The patient will be instructed to make a bold dot on the line based on how they rate their first step heel pain, using the parameters listed on the scale (0 meaning no pain, 20 meaning mild pain, 50 meaning moderate pain, 80 meaning extreme pain, and 100 meaning the worst pain imaginable). Range = 0-100 mm.
Change in Foot Function Index (FFI) scores
Zero represents no pain/disability, and 10 represents the worst pain imaginable/severe disability for each item - scores between 0 to 170 points as an overall score - sub-category scores (pain - total of 50 points max, disability - total of 90 points max, and activity limitation - total of 30 points max).
Change in Foot Function Index (FFI) scores
Zero represents no pain/disability, and 10 represents the worst pain imaginable/severe disability for each item - scores between 0 to 170 points as an overall score - sub-category scores (pain - total of 50 points max, disability - total of 90 points max, and activity limitation - total of 30 points max).
Change in Foot Function Index (FFI) scores
Zero represents no pain/disability, and 10 represents the worst pain imaginable/severe disability for each item - scores between 0 to 170 points as an overall score - sub-category scores (pain - total of 50 points max, disability - total of 90 points max, and activity limitation - total of 30 points max).
Change in Foot Function Index (FFI) scores
Zero represents no pain/disability, and 10 represents the worst pain imaginable/severe disability for each item - scores between 0 to 170 points as an overall score - sub-category scores (pain - total of 50 points max, disability - total of 90 points max, and activity limitation - total of 30 points max).
Change in Foot Function Index (FFI) scores
Zero represents no pain/disability, and 10 represents the worst pain imaginable/severe disability for each item - scores between 0 to 170 points as an overall score - sub-category scores (pain - total of 50 points max, disability - total of 90 points max, and activity limitation - total of 30 points max).

Secondary Outcome Measures

Exit Survey Scores
Upon completion of study related procedures and assessments, participants will be given a paper exit survey to complete. 5 questions will be asked relating to their experience in the study and if they would recommend the study to others. The first question asks participants to rate their experience [range = 1(worst experience) -10 (best experience)]. The next two questions will be answered by circling "yes" and "no". Questions 4 and 5 are free-response questions where participants will be able to document their likes and dislikes of the study.
Patient Exercise Diary Results
Participants will document daily if they have completed any of the 3 recommended exercises (calf stretching, plantar fascia specific stretching, and loading exercise) . They will also be asked to document why they did not complete any exercises if applicable to them daily.
heel pressure threshold scores
Using a dolorimeter, the PI will assess each participant's heel pressure threshold - describe the level of pain on a 10-point scale, with 0 meaning no pain and 10 meaning extreme pain.
heel tenderness scores
this study will utilize the heel tenderness index which has a range of 0 - 3 points (0 points = no pain, 1 point = painful, 2 points = painful and winces, 3 points = painful, winces, and withdraws). The physician will assess heel pain on palpation.

Full Information

First Posted
May 11, 2023
Last Updated
September 28, 2023
Sponsor
Wake Forest University Health Sciences
search

1. Study Identification

Unique Protocol Identification Number
NCT05868577
Brief Title
Infracalcaneal Peppering Injection Technique for Chronic Plantar Fasciitis
Official Title
Infracalcaneal Peppering Injection Technique for Chronic Plantar Fasciitis: Protocol for a Parallel Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
November 2023 (Anticipated)
Primary Completion Date
October 2024 (Anticipated)
Study Completion Date
October 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Wake Forest University Health Sciences

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Although no single treatment has shown superiority, short-term pain relief may be offered via a targeted local corticosteroid injection (CSI), used often in combination with local anesthetic (LA), which may reduce plantar fasciitis symptoms for up to 1 month. Moreover, administering a CSI is relatively quick and easy for any Provider to perform, though it is not without potential deleterious side effects and risks, including fibroblast degradation, fat pad atrophy, skin depigmentation, and even plantar fascia rupture.
Detailed Description
Research performed in other musculoskeletal disorders (e.g. lateral epicondylitis) suggest that the "method" (i.e peppering vs single bolus deposition) of injection is more favorable than the steroid itself, though evidence for this positive effect in plantar fasciitis is rather scarce. Injection via peppering is a minimally invasive percutaneous technique which involves repeatedly fenestrating the pathologic site (i.e. plantar fascia) via hypodermic needle insertion at the tender area, then sequentially injecting a substance, withdrawing, redirecting, and reinserting all without emerging from the skin. Though hypothetical, this technique is thought to disrupt the degenerative process of Plantar Fasciitis (PF), encouraging both localized bleeding and fibroblastic proliferation and stimulating a local inflammatory response that would trigger the body's own reparative mechanism, leading to recovery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Plantar Fasciitis
Keywords
corticosteroid injection, infracalcaneal peppering injection, Plantar Fasciitis

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Parallel Assignment
Model Description
All patients ages 18 years and up with a diagnosis of plantar heel pain will be screened for inclusion into the study.
Masking
ParticipantInvestigator
Masking Description
A nurse or staff member will open a previously prepared and sealed opaque envelope (prepared beforehand by the clinical coordinator) labeled with the participant identification (ID) of the patient, which will be unique to the individual and different from their Medical Record Number (MRN). In this envelope, they will discover the patient's assigned treatment arm. The nurse or staff member will then prepare the syringe with the assigned treatment arm. Once the syringe is filled with the designated substance, the syringe will be wrapped with opaque tape or dark Coban wrap to conceal the contents in the syringe for both the PI and study participant.
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
corticosteroid injection/ local anesthetic (CSI/LA)
Arm Type
Experimental
Arm Description
The PI will then administer the (CSI/LA) injection using an infracalcaneal needle peppering technique as follows: The hypodermic needle is inserted using infracalcaneal injection approach. The hypodermic needle is withdrawn while at the same depositing injectate The hypodermic needle is redirected without emerging from the skin. The PI will perform steps 1-3 standardly 20-25 times.
Arm Title
local anesthetic (LA)/Saline injection
Arm Type
Placebo Comparator
Arm Description
The PI will then administer the (LA/Saline) injection using an infracalcaneal needle peppering technique as follows: The hypodermic needle is inserted using infracalcaneal injection approach. The hypodermic needle is withdrawn while at the same depositing injectate The hypodermic needle is redirected without emerging from the skin. The PI will perform steps 1-3 standardly 20-25 times.
Intervention Type
Drug
Intervention Name(s)
Corticosteroid injection (CSI) with local anesthetic (LA)
Other Intervention Name(s)
Corticosteroid injection
Intervention Description
The PI will then administer the injection using an infracalcaneal needle peppering
Intervention Type
Drug
Intervention Name(s)
Local anesthetic (LA) with Saline injection
Other Intervention Name(s)
Local anesthetic injection
Intervention Description
The PI will then administer the injection using an infracalcaneal needle peppering
Primary Outcome Measure Information:
Title
Change in Visual Analog Scale as a Comprehensible Patient-Reported Outcome Measure (VAS PROM) scores - heel tenderness
Description
"general heel pain" - A sheet of paper with a printed VAS scale will be given to the patient. The patient will be instructed to make a bold dot on the line based on how they rate their general heel pain, using the parameters listed on the scale (0 meaning no pain, 20 meaning mild pain, 50 meaning moderate pain, 80 meaning extreme pain, and 100 meaning the worst pain imaginable). Range = 0-100 mm.
Time Frame
Baseline
Title
Change in Visual Analog Scale as a Comprehensible Patient-Reported Outcome Measure (VAS PROM) scores - heel tenderness
Description
"general heel pain" - A sheet of paper with a printed VAS scale will be given to the patient. The patient will be instructed to make a bold dot on the line based on how they rate their general heel pain, using the parameters listed on the scale (0 meaning no pain, 20 meaning mild pain, 50 meaning moderate pain, 80 meaning extreme pain, and 100 meaning the worst pain imaginable). Range = 0-100 mm.
Time Frame
Week 2
Title
Change in Visual Analog Scale as a Comprehensible Patient-Reported Outcome Measure (VAS PROM) scores - heel tenderness
Description
"general heel pain" - A sheet of paper with a printed VAS scale will be given to the patient. The patient will be instructed to make a bold dot on the line based on how they rate their general heel pain, using the parameters listed on the scale (0 meaning no pain, 20 meaning mild pain, 50 meaning moderate pain, 80 meaning extreme pain, and 100 meaning the worst pain imaginable). Range = 0-100 mm.
Time Frame
Week 4
Title
Change in Visual Analog Scale as a Comprehensible Patient-Reported Outcome Measure (VAS PROM) scores - heel tenderness
Description
"general heel pain" - A sheet of paper with a printed VAS scale will be given to the patient. The patient will be instructed to make a bold dot on the line based on how they rate their general heel pain, using the parameters listed on the scale (0 meaning no pain, 20 meaning mild pain, 50 meaning moderate pain, 80 meaning extreme pain, and 100 meaning the worst pain imaginable). Range = 0-100 mm.
Time Frame
Week 8
Title
Change in Visual Analog Scale as a Comprehensible Patient-Reported Outcome Measure (VAS PROM) scores - heel tenderness
Description
"general heel pain" - A sheet of paper with a printed VAS scale will be given to the patient. The patient will be instructed to make a bold dot on the line based on how they rate their general heel pain, using the parameters listed on the scale (0 meaning no pain, 20 meaning mild pain, 50 meaning moderate pain, 80 meaning extreme pain, and 100 meaning the worst pain imaginable). Range = 0-100 mm.
Time Frame
Week 12
Title
Change in Visual Analog Scale as a Comprehensible Patient-Reported Outcome Measure (VAS PROM) scores - first step pain
Description
"first step pain" - A sheet of paper with a printed VAS scale will be given to the patient. The patient will be instructed to make a bold dot on the line based on how they rate their first step heel pain, using the parameters listed on the scale (0 meaning no pain, 20 meaning mild pain, 50 meaning moderate pain, 80 meaning extreme pain, and 100 meaning the worst pain imaginable). Range = 0-100 mm.
Time Frame
Baseline
Title
Change in Visual Analog Scale as a Comprehensible Patient-Reported Outcome Measure (VAS PROM) scores - first step pain
Description
"first step pain" - A sheet of paper with a printed VAS scale will be given to the patient. The patient will be instructed to make a bold dot on the line based on how they rate their first step heel pain, using the parameters listed on the scale (0 meaning no pain, 20 meaning mild pain, 50 meaning moderate pain, 80 meaning extreme pain, and 100 meaning the worst pain imaginable). Range = 0-100 mm.
Time Frame
Week 2
Title
Change in Visual Analog Scale as a Comprehensible Patient-Reported Outcome Measure (VAS PROM) scores - first step pain
Description
"first step pain" - A sheet of paper with a printed VAS scale will be given to the patient. The patient will be instructed to make a bold dot on the line based on how they rate their first step heel pain, using the parameters listed on the scale (0 meaning no pain, 20 meaning mild pain, 50 meaning moderate pain, 80 meaning extreme pain, and 100 meaning the worst pain imaginable). Range = 0-100 mm.
Time Frame
Week 4
Title
Change in Visual Analog Scale as a Comprehensible Patient-Reported Outcome Measure (VAS PROM) scores - first step pain
Description
"first step pain" - A sheet of paper with a printed VAS scale will be given to the patient. The patient will be instructed to make a bold dot on the line based on how they rate their first step heel pain, using the parameters listed on the scale (0 meaning no pain, 20 meaning mild pain, 50 meaning moderate pain, 80 meaning extreme pain, and 100 meaning the worst pain imaginable). Range = 0-100 mm.
Time Frame
Week 8
Title
Change in Visual Analog Scale as a Comprehensible Patient-Reported Outcome Measure (VAS PROM) scores - first step pain
Description
"first step pain" - A sheet of paper with a printed VAS scale will be given to the patient. The patient will be instructed to make a bold dot on the line based on how they rate their first step heel pain, using the parameters listed on the scale (0 meaning no pain, 20 meaning mild pain, 50 meaning moderate pain, 80 meaning extreme pain, and 100 meaning the worst pain imaginable). Range = 0-100 mm.
Time Frame
Week 12
Title
Change in Foot Function Index (FFI) scores
Description
Zero represents no pain/disability, and 10 represents the worst pain imaginable/severe disability for each item - scores between 0 to 170 points as an overall score - sub-category scores (pain - total of 50 points max, disability - total of 90 points max, and activity limitation - total of 30 points max).
Time Frame
Baseline
Title
Change in Foot Function Index (FFI) scores
Description
Zero represents no pain/disability, and 10 represents the worst pain imaginable/severe disability for each item - scores between 0 to 170 points as an overall score - sub-category scores (pain - total of 50 points max, disability - total of 90 points max, and activity limitation - total of 30 points max).
Time Frame
Week 2
Title
Change in Foot Function Index (FFI) scores
Description
Zero represents no pain/disability, and 10 represents the worst pain imaginable/severe disability for each item - scores between 0 to 170 points as an overall score - sub-category scores (pain - total of 50 points max, disability - total of 90 points max, and activity limitation - total of 30 points max).
Time Frame
Week 4
Title
Change in Foot Function Index (FFI) scores
Description
Zero represents no pain/disability, and 10 represents the worst pain imaginable/severe disability for each item - scores between 0 to 170 points as an overall score - sub-category scores (pain - total of 50 points max, disability - total of 90 points max, and activity limitation - total of 30 points max).
Time Frame
Week 8
Title
Change in Foot Function Index (FFI) scores
Description
Zero represents no pain/disability, and 10 represents the worst pain imaginable/severe disability for each item - scores between 0 to 170 points as an overall score - sub-category scores (pain - total of 50 points max, disability - total of 90 points max, and activity limitation - total of 30 points max).
Time Frame
Week 12
Secondary Outcome Measure Information:
Title
Exit Survey Scores
Description
Upon completion of study related procedures and assessments, participants will be given a paper exit survey to complete. 5 questions will be asked relating to their experience in the study and if they would recommend the study to others. The first question asks participants to rate their experience [range = 1(worst experience) -10 (best experience)]. The next two questions will be answered by circling "yes" and "no". Questions 4 and 5 are free-response questions where participants will be able to document their likes and dislikes of the study.
Time Frame
Week12
Title
Patient Exercise Diary Results
Description
Participants will document daily if they have completed any of the 3 recommended exercises (calf stretching, plantar fascia specific stretching, and loading exercise) . They will also be asked to document why they did not complete any exercises if applicable to them daily.
Time Frame
Week 2, Week 4, Week 8, and Week12
Title
heel pressure threshold scores
Description
Using a dolorimeter, the PI will assess each participant's heel pressure threshold - describe the level of pain on a 10-point scale, with 0 meaning no pain and 10 meaning extreme pain.
Time Frame
Baseline, Week 2, Week 4, Week 8, and Week 12
Title
heel tenderness scores
Description
this study will utilize the heel tenderness index which has a range of 0 - 3 points (0 points = no pain, 1 point = painful, 2 points = painful and winces, 3 points = painful, winces, and withdraws). The physician will assess heel pain on palpation.
Time Frame
Baseline, Week 2, Week 4, Week 8, and Week 12

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Men and women 18 years of age and older Patient reported history of plantar heel pain and confirmed clinical tenderness of pain with direct palpation of the medial calcaneal tubercle on baseline exam Diagnosis of chronic plantar fasciitis, defined for study purposes as symptoms greater than or equal to 6 weeks in duration Exclusion Criteria: Individuals less than 18 years of age Pregnancy History of local heel injection (i.e. corticosteroid injection (CSI) or other injectate) History of diabetes mellitus History of inflammatory arthritis Prior heel trauma or surgery Allergy to local corticosteroid or local anesthesia
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Blevins Maria
Phone
336.716.9994
Email
mablevin@wakehealth.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael A Jones, DPM
Organizational Affiliation
Wake Forest University Health Sciences
Official's Role
Principal Investigator
Facility Information:
Facility Name
Wake Forest University Health Sciences
City
Winston-Salem
State/Province
North Carolina
ZIP/Postal Code
27157
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maria A Blevins
Phone
336-716-9994
Email
mablevin@wakehealth.edu
First Name & Middle Initial & Last Name & Degree
Michael A Jones, DPM

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Infracalcaneal Peppering Injection Technique for Chronic Plantar Fasciitis

We'll reach out to this number within 24 hrs